Veterinary Point Of Care Diagnostics Market - Global Forecast 2025-2032

The veterinary point of care diagnostics market is experiencing robust momentum, fueled by increasing clinical expectations, advances in portable technologies, and a growing emphasis on timely animal health interventions in both companion and livestock segments.

Market Snapshot: Veterinary Point of Care Diagnostics Market Size and Growth Outlook

The global veterinary point of care diagnostics market grew from USD 1.94 billion in 2024 to USD 2.19 billion in 2025. Market expansion is projected to continue at a CAGR of 12.58%, with revenues anticipated to reach USD 5.03 billion by 2032. This trajectory highlights expanding adoption across animal health settings, from clinics and hospitals to field-based livestock operations, as stakeholders prioritize faster, more actionable diagnostic insights.

Scope & Segmentation of the Veterinary Point of Care Diagnostics Market

• Animal Types: Companion animals (cats, dogs) and livestock (cattle, horses, poultry, swine)
• Test Types: Biochemistry (chemistry analyzers, electrolyte analyzers), hematology (cell counters, hemoglobin analyzers), immunoassay (ELISA, lateral flow assays), and molecular diagnostics
• End Users: Diagnostic laboratories, hospitals and clinics, research institutes
• Technology: Reader based and reader less platforms
• Applications: Cardiac monitoring, critical care, infectious disease, metabolic screening
• Sample Types: Blood, feces, milk, saliva, urine
• Regions: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, UAE, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
• Key Companies: IDEXX Laboratories, Inc., Zoetis Inc., Heska Corporation, Abaxis, Inc., Mars, Inc., FUJIFILM Holdings Corporation, Nova Biomedical Corporation, bioMérieux SA, Abbott Laboratories, QIAGEN N.V.

Key Takeaways for Senior Decision-Makers

• Decentralization of diagnostics is driving efficiency in animal health management, enabling rapid, near-patient testing across clinics and on farms.
• Technological advances, such as miniaturized analyzers and user-friendly interfaces, are broadening market accessibility and supporting both routine and critical veterinary workflows.
• Companion animal sectors are seeing increased uptake as pet ownership rises, while livestock applications are supporting herd productivity and biosecurity through early disease detection.
• Sustained focus on regulatory compliance, especially antimicrobial stewardship, is fostering demand for precise diagnostics to inform evidence-based treatment.
• Supply chain adaptability, including the exploration of nearshoring and local partnerships, is emerging as a strategic response to tariff fluctuations and import duties.
• Competitive differentiation centers on product innovation, integration with digital veterinary systems, and specialized training to enhance end-user proficiency.

Tariff Impact on Veterinary Diagnostic Supply Chains

Amendments to United States tariff policies in 2025 have added complexity to sourcing for essential reagents and diagnostic components. Manufacturers are revising procurement strategies, considering alternative regions, and exploring increased domestic production to stabilize supply and control costs. These dynamics are prompting higher collaboration between distributors and suppliers to buffer inventory and minimize disruptions for end customers.

Veterinary Point of Care Diagnostics Market: Methodology & Data Sources

This report relies on a robust methodology combining in-depth interviews with veterinary professionals, laboratory directors, and industry leaders as primary sources. Systematic analysis of peer-reviewed journals, regulatory filings, and industry whitepapers enabled context-rich secondary validation. Analytical triangulation was applied to cross-verify trends and ensure consistency in findings.

Why This Report Matters: Strategic Insights for Industry Leaders

• Empowers decision-makers to identify growth opportunities amid complex clinical, regulatory, and supply chain environments by leveraging reliable market intelligence.
• Delivers actionable segmentation and technology insights, aiding prioritization of investments in innovation, manufacturing, and market expansion strategies.
• Facilitates risk assessment and operational planning to address market volatility and evolving animal health imperatives.

Conclusion

Veterinary point of care diagnostics continue to transform global animal health by improving both speed and quality of clinical decision-making. Stakeholders adopting adaptable, technology-driven platforms are positioned to respond effectively to changing market and regulatory demands.

 

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.